Cardiawave SA, a deeptech medical device manufacturer that developed Valvosoft, a non-invasive medical device to treat aortic stenosis, announced the issuance of three new patents in the United States.
Ultromics' EchoGo Heart Failure, an AI solution for echocardiography to help diagnosis heart failure, received FDA clearance.
CardieX Limited filed a 510(k) premarket submission with the U.S. FDA for a dual blood pressure and arterial health monitor.
Cardiawave SA, a deeptech medical device manufacturer that developed Valvosoft, a non-invasive medical device to treat aortic stenosis, announced the issuance of three new patents in the United States.
The ChEVAS System is an investigational endovascular abdominal aortic aneurysm (AAA) sealing therapy designed to combine the Nellix 3.5 endograft with parallel visceral stents to enable treatment of patients with juxtarenal, pararenal, and suprarenal AAA.
Read More
“Looking forward, we remain committed to our medical distribution and global medical products businesses,” says Cardinal Health’s CEO.
Read More
Vivid Ultra Edition cardiovascular ultrasound features leverage AI-driven, neural network-based algorithms to deliver repeatable and faster measurements in 2D echo imaging.
Read More
The 3-year agreement will support interdisciplinary research projects focusing on better data sharing, care pathways, integration of medical services, and tracking outcomes.
Read More